Letter seeks clarity on semaglutide compounding in California

Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.

The letter is the result of several reports of conflicting statements from California BOP staff that seemed to deviate from current FDA guidance on shortage drug compounding.

Consider this a teaser. Sometime in late spring, we’ll be debuting a new 15-hour certificate...

Earlier this week, APC sent a letter to the California Board of Pharmacy requesting clarification...

We’ve been bugging the California Board of Pharmacy (politely!) for a while, trying to get a...

Letter seeks clarity on semaglutide compounding in California

Related posts

Coming soon: Compounding certificate program for your new hires

APC sends follow up to CA BOP

GLP-1s: A California clarification of sorts